サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1657234

先天性代謝異常用医療食品の世界市場：2034年までの機会と戦略

Medical Foods For Inborn Errors Of Metabolism Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 318 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
先天性代謝異常用医療食品の世界市場：2034年までの機会と戦略
出版日: 2025年02月17日
発行: The Business Research Company
ページ情報: 英文 318 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

先天性代謝異常用医療食品の世界市場は、2019年に19億1,520万米ドルと評価され、2024年までCAGR9.00％以上で成長しました。

ヘルスケアインフラの拡大

ヘルスケアインフラの拡大は、実績期間における先天性代謝異常用医療食品の市場の成長を支えました。ヘルスケア施設の拡大は、特に新生児スクリーニング・プログラムの強化を通じて診断能力を強化しました。インフラの強化は先天性代謝異常の早期発見を容易にし、こうした状態を管理するために設計された特殊な医療用食品に対する需要の増大を促しました。例えば、2023年1月、財務大臣が国会で発表した2022-23年度経済調査によると、2023会計年度（FY23）に中央政府と州政府の両方から割り当てられた医療費は国内総生産（GDP）の2.1%に達し、FY22の2.2%、FY21の1.6%から増加しました。さらに、米国の非営利団体であるカナダ医療情報研究所によると、2023年にはカナダの総医療費は3,440億米ドル、1人当たり8,740ドルに達すると予測されています。病院費用は2023年に4.1％、2022年には11.1％増加すると予測されています。医師支出の伸びは、2023年には6.9％、2022年には9.5％と予測されています。したがって、ヘルスケア・インフラの拡大が先天性代謝異常用医療食品の成長を支えています。

目次

第1章 エグゼクティブサマリー

  • 先天性代謝異常用医療食品-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 先天性代謝異常用医療食品市場定義とセグメンテーション
  • 製品別：市場セグメンテーション
    • アミノ酸ベースの医療食品
    • グリタクチンGMPアミノ酸調整乳児用調製乳（鉄分配合）
    • 低カルシウム/ビタミンD不使用、鉄分配合乳児用調製乳
    • 低タンパク質食品
    • その他の製品
  • 形態別：市場セグメンテーション
    • 粉
    • 液体
    • ジェル
    • その他の形式
  • 流通チャネル別：市場セグメンテーション
    • 小売薬局
    • 病院薬局
    • ドラッグストア
    • オンライン薬局
    • その他の流通チャネル
  • 疾患別：市場セグメンテーション
    • フェニルケトン尿症（PKU）
    • 有機酸尿症
    • ホモシスチン尿症
    • ロイシン代謝障害
    • グルタル酸血症I型腎疾患
    • その他の疾患
  • 年齢層別：市場セグメンテーション
    • 乳児
    • 離乳
    • 思春期
    • 大人

第7章 主要な市場動向

  • 患者登録プラットフォームによる先天性代謝異常の個別化治療の進歩
  • フェニルケトン尿症治療のためのアミノ酸ベースの新医療食品発売
  • 代謝障害管理におけるアンメットニーズに対応する革新的なチロシン血症錠剤を発売

第8章 先天性代謝異常用医療食品市場：マクロ経済シナリオ

  • COVID-19の影響：先天性代謝異常用医療食品市場
  • ウクライナ戦争の影響：先天性代謝異常用医療食品市場
  • 高インフレの影響：先天性代謝異常用医療食品市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2019-2024
    • 市場促進要因2019-2024
    • 市場抑制要因2019-2024
  • 市場成長予測, 2024-2029, 2034F
    • 市場促進要因2024-2029
    • 市場抑制要因2024-2029

第10章 世界の先天性代謝異常用医療食品市場：セグメンテーション

  • 世界の先天性代謝異常用医療食品市場：製品別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の先天性代謝異常用医療食品市場：形態別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の先天性代謝異常用医療食品市場：流通チャネル別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の先天性代謝異常用医療食品市場：疾患別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の先天性代謝異常用医療食品市場：年齢層別、実績と予測, 2019-2024, 2029F, 2034F

第11章 先天性代謝異常用医療食品市場：地域・国別分析

  • 世界の先天性代謝異常用医療食品市場：地域別、実績と予測, 2019-2024, 2029F, 2034F
  • 世界の先天性代謝異常用医療食品市場：国別、実績と予測, 2019-2024, 2029F, 2034F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Fresenius SE & Co. KGaA
  • Nestle S.A.
  • Abbott Laboratories
  • Mount Sinai Health System Inc
  • Danone S.A

第20章 その他の大手企業と革新的企業

  • Ajinomoto Co. Inc
  • Reckitt Benckiser Group plc（Mead Johnson & Company, LLC）
  • Galen Limited
  • BC Children's Hospital
  • Metagenics Inc
  • Leadiant Biosciences Inc
  • Pristine Organics Pvt. Ltd
  • PIAM Farmaceutici S.p.A
  • Solace Nutrition LLC
  • Zoia Pharma Inc
  • Hexagon Nutrition Ltd
  • Biovencer Healthcare Pvt. Ltd
  • Orpharma Pty Ltd
  • Primus Pharmaceuticals Inc
  • Meiji Holdings Co. Ltd

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Otsuka Pharmaceutical Acquired Jnana Therapeutics To Expand Metabolic Disorder Portfolio

第24章 機会と戦略

  • 世界の先天性代謝異常用医療食品市場2029：新たな機会を提供する国
  • 世界の先天性代謝異常用医療食品市場2029：新たな機会を提供するセグメント
  • 世界の先天性代謝異常用医療食品市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 先天性代謝異常用医療食品市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1478

Medical foods for inborn errors of metabolism (IEM) are specially formulated dietary products intended to meet the unique nutritional requirements of individuals diagnosed with specific metabolic disorders. These conditions, detected in early childhood through newborn screening, arise from genetic defects that impair the body's ability to metabolize certain nutrients, such as amino acids, carbohydrates, or fats.

The medical foods for inborn errors of metabolism market consists of sales, by entities (organizations, sole traders, or partnerships) of medical foods for inborn errors of metabolism that are primarily consumed by individuals diagnosed with rare metabolic disorders, and may be purchased by their caregivers and healthcare providers, who help manage their conditions. These products are used throughout life, as many of these metabolic conditions are chronic and require continuous dietary regulation.

The global medical foods for inborn errors of metabolism market was valued at $1,915.20 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.

Expanding Healthcare Infrastructure

Expanding healthcare infrastructure supported the growth of medical foods for inborn errors in the metabolism market in the historic period. The expansion of healthcare facilities strengthened diagnostic capabilities, particularly through enhanced newborn screening programs. The enhanced infrastructure facilitates the early detection of inborn errors of metabolism, drove higher demand for specialized medical foods designed to manage these conditions. For instance, in January 2023, according to the Economic Survey 2022-23 presented by the finance minister in Parliament, the allocated healthcare expenditure by both central and state governments reached 2.1% of gross domestic product (GDP) in the fiscal year 2023 (FY23), up from 2.2% in FY22 and 1.6% in FY21. Additionally, according to the Canadian Institute for Health Information, a US-based not-for-profit organization, it is projected that in 2023, Canada's total health spending is expected to reach $344 billion or $8,740 per person. It is anticipated that hospital costs will rise by 4.1% in 2023 and 11.1% in 2022. The growth in physician spending is predicted to be 6.9% in 2023 and 9.5% in 2022. Therefore, expanding healthcare infrastructure supported the growth of medical foods for inborn errors in the metabolism market.

New Amino Acid-Based Medical Food Launched For Phenylketonuria Management

Major companies in the medical foods for inborn errors of metabolism market are focusing on developing innovative products, such as low-phenylalanine amino acid foods, to address the nutritional needs of patients with metabolic disorders. These innovations help manage the nutritional challenges posed by conditions such as phenylketonuria (PKU), improving patient health outcomes. For instance, In October 2024, PhenylAde, the Netherlands-based company that specialized medical nutrition products, launched PhenylAde(R) GMP ULTRA Plain. It is an amino acid-based medical food tailored for individuals with PKU. It features a specialized formulation that delivers essential nutrients while excluding phenylalanine, providing a crucial dietary solution for PKU management. Designed to support optimal growth and development, particularly in those with metabolic disorders, the product is free from artificial sweeteners and flavors, ensuring both safety and palatability.

The global medical foods for inborn errors of metabolism market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 21.88% of the total market in 2023.

Medical Foods For Inborn Errors Of Metabolism Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global medical foods for inborn errors of metabolism market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for medical foods for inborn errors of metabolism? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The medical foods for inborn errors of metabolism market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider medical foods for inborn errors of metabolism market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by forms, by distribution channel, by disease and by age group.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the medical foods for inborn errors of metabolism market.
  • Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by forms, by distribution channel, by disease and by age group in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for medical foods for inborn errors of metabolism providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Amino Acid-Based Medical Foods; Glytactin With GMP Amino Acid-Modified Infant Formula With Iron; Low-Calcium/Vitamin D-Free Infant Formula With Iron; Low Protein Food; Other Products
  • 2) By Forms: Powder; Liquids; Gels; Other Forms
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Drugs Stores; Online Pharmacies; Other Distribution Channels
  • 4) By Diseases: Phenylketonuria (PKU); Organic Acidurias; Homocystinuria; Disorders Of Leucine Metabolism; Glutaric Acidemia Type I Renal Disease; Other Diseases
  • 5) By Age Group: Infants; Weaning; Adolescent; Adults
  • Companies Mentioned: Fresenius Kabi; Nestle S.A.; Abbott Laboratories Inc.; Mount Sinai Health System Inc.; Danone SA
  • Countries: China; Australia; India; Indonesia; Japan; South KoreaUSA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; medical foods for inborn errors of metabolism indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Medical Foods For Inborn Errors Of Metabolism - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Medical Foods For Inborn Errors Of Metabolism Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Amino Acid-Based Medical Foods
    • 6.4.2 Glytactin With GMP Amino Acid-Modified Infant Formula With Iron
    • 6.4.3 Low-Calcium/ Vitamin D- Free Infant Formula With Iron
    • 6.4.4 Low Protein Food
    • 6.4.5 Other Products
  • 6.5 Market Segmentation By Forms
    • 6.5.1 Powder
    • 6.5.2 Liquids
    • 6.5.3 Gels
    • 6.5.4 Other Forms
  • 6.6 Market Segmentation By Distribution Channel
    • 6.6.1 Retail Pharmacies
    • 6.6.2 Hospital Pharmacies
    • 6.6.3 Drug Stores
    • 6.6.4 Online Pharmacies
    • 6.6.5 Other Distribution Channels
  • 6.7 Market Segmentation By Diseases
    • 6.7.1 Phenylketonuria (PKU)
    • 6.7.2 Organic Acidurias
    • 6.7.3 Homocystinuria
    • 6.7.4 Disorders Of Leucine Metabolism
    • 6.7.5 Glutaric Of Acidemia Type I Renal Disease
    • 6.7.6 Other Diseases
  • 6.8 Market Segmentation By Age Group
    • 6.8.1 Infants
    • 6.8.2 Weaning
    • 6.8.3 Adolescent
    • 6.8.4 Adults

7 Major Market Trends

  • 7.1 Advancements In Personalized Treatment For Inborn Errors Of Metabolism Through Patient Registry Platforms
  • 7.2 New Amino Acid-Based Medical Food Launched For Phenylketonuria Management
  • 7.3 Innovative Tyrosinemia Tablets Launched To Address Unmet Needs In Metabolic Disorder Management

8 Medical Foods For Inborn Errors Of Metabolism Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Medical Foods For Inborn Errors Of Metabolism Market
  • 8.2 Impact Of The War In Ukraine On The Medical Foods For Inborn Errors Of Metabolism Market
  • 8.3 Impact Of High Inflation On The Medical Foods For Inborn Errors Of Metabolism Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 9.2.1 Market Drivers 2019 - 2024
    • 9.2.2 Market Restraints 2019 - 2024
  • 9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 9.3.1 Market Drivers 2024 - 2029
    • 9.3.2 Market Restraints 2024 - 2029

10 Global Medical Foods For Inborn Errors Of Metabolism Market Segmentation

  • 10.1 Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.3 Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.4 Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.5 Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Medical Foods For Inborn Errors Of Metabolism Market, Regional and Country Analysis

  • 11.1 Global Medical Foods For Inborn Errors Of Metabolism Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.2 Global Medical Foods For Inborn Errors Of Metabolism Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Major Companies
  • 12.3 Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulatory Bodies
    • 12.9.6 Major Associations
    • 12.9.7 Taxes Levied
    • 12.9.8 Corporate Tax Structure
    • 12.9.9 Major Companies
  • 12.10 China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.12 China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.16 India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.2 Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.24 Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.27 Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.28 Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.31 South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.32 South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Western Europe Medical Foods For Inborn Errors Of Metabolism Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.13 Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.14 Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.17 France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.18 France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.21 Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.22 Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.25 Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.26 Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major companies
  • 14.3 Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.9 Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.10 Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 North America Medical Foods For Inborn Errors Of Metabolism Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.11 USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.12 USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.15 Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.16 Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.6 South America Medical Foods For Inborn Errors Of Metabolism Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.9 Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.10 Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major Companies
  • 18.3 Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.4 Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Form, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.5 Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Fresenius SE & Co. KGaA
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Financial Overview
  • 19.3 Nestle S.A.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Abbott Laboratories
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Mount Sinai Health System Inc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial Overview
  • 19.6 Danone S.A
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Ajinomoto Co. Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)
    • 20.2.1 Company Overview
    • 20.2.2 Products and Services
  • 20.3 Galen Limited
    • 20.3.1 Company Overview
    • 20.3.2 Products and Services
  • 20.4 BC Children's Hospital
    • 20.4.1 Company Overview
    • 20.4.2 Products and Services
  • 20.5 Metagenics Inc
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 Leadiant Biosciences Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 Pristine Organics Pvt. Ltd
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 PIAM Farmaceutici S.p.A
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Solace Nutrition LLC
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.10 Zoia Pharma Inc
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 Hexagon Nutrition Ltd
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 Biovencer Healthcare Pvt. Ltd
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 Orpharma Pty Ltd
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services
  • 20.14 Primus Pharmaceuticals Inc
    • 20.14.1 Company Overview
    • 20.14.2 Products and Services
  • 20.15 Meiji Holdings Co. Ltd
    • 20.15.1 Company Overview
    • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Otsuka Pharmaceutical Acquired Jnana Therapeutics To Expand Metabolic Disorder Portfolio

24 Opportunities And Strategies

  • 24.1 Global Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Medical Foods For Inborn Errors Of Metabolism Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer